B
Power Law company profile
BlueRock Therapeutics
Biotech & Life Sciences · Cambridge, United States · Founded 2016 Unicorn
Global footprint
Where BlueRock Therapeutics has talent and traffic
Web traffic by country
27K
monthly visits
across markets
across markets
🇺🇸 United States60%
🇨🇦 Canada20.4%
🇮🇳 India17%
🇩🇪 Germany3.7%
Patent intelligence
$2M patent portfolio · 23 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$2M
0.19% of valuation · 82.9× smaller than top peer Exelixis ($161M)
23 active patent families
Where BlueRock Therapeutics innovates
Molecular biologyCell biologyBiochemistryBiomedical engineeringCell
Below peer median on Legal, Market, Economic, Technology
Quality vs same-sector peers
BlueRock Therapeutics on the five Patsnap quality dimensions
BlueRock Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where BlueRock Therapeutics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across BlueRock Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee BlueRock Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.